Literature DB >> 14667859

Conservative treatment may be beneficial for young women with atypical endometrial hyperplasia or endometrial adenocarcinoma.

Pascale Jadoul1, Jacques Donnez.   

Abstract

OBJECTIVE: To evaluate whether an alternative treatment to radical hysterectomy exists for young women with endometrial adenocarcinoma.
DESIGN: A review of the literature (70 articles) plus personal results.
SETTING: University hospital. PATIENT(S): Women with atypical endometrial hyperplasia or adenocarcinoma. MAIN OUTCOME MEASURE(S): The recurrence rate and the pregnancy rate after conservative therapy. CONCLUSION(S): Conservative treatment of well-differentiated stage I endometrial adenocarcinoma can be considered in young patients, with close surveillance to diagnose any possible recurrence.

Entities:  

Mesh:

Year:  2003        PMID: 14667859     DOI: 10.1016/s0015-0282(03)01183-x

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  24 in total

1.  Endometrial progesterone receptor isoforms in women with polycystic ovary syndrome.

Authors:  Min Hu; Juan Li; Yuehui Zhang; Xin Li; Mats Brännström; Linus R Shao; Håkan Billig
Journal:  Am J Transl Res       Date:  2018-08-15       Impact factor: 4.060

Review 2.  Contemporary quality of life issues affecting gynecologic cancer survivors.

Authors:  Jeanne Carter; Richard Penson; Richard Barakat; Lari Wenzel
Journal:  Hematol Oncol Clin North Am       Date:  2011-12-16       Impact factor: 3.722

3.  Epithelial membrane protein-2 expression is an early predictor of endometrial cancer development.

Authors:  Omar Habeeb; Lee Goodglick; Robert A Soslow; Rajiv G Rao; Lynn K Gordon; Osvaldo Schirripa; Steve Horvath; Jonathan Braun; David B Seligson; Madhuri Wadehra
Journal:  Cancer       Date:  2010-10-15       Impact factor: 6.860

4.  The effectiveness of levonorgestrel releasing intrauterine system in the treatment of endometrial hyperplasia in Korean women.

Authors:  Seo Yeong Lee; Mi Kyoung Kim; Hyun Park; Bo Sung Yoon; Seok Ju Seong; Jin Hee Kang; Hye Sun Jun; Chong Taik Park
Journal:  J Gynecol Oncol       Date:  2010-06-30       Impact factor: 4.401

Review 5.  Progesterone receptor action in leiomyoma and endometrial cancer.

Authors:  J Julie Kim; Elizabeth C Sefton; Serdar E Bulun
Journal:  Prog Mol Biol Transl Sci       Date:  2009-10-07       Impact factor: 3.622

6.  ESGO/ESTRO/ESP Guidelines for the management of patients with endometrial carcinoma.

Authors:  Nicole Concin; Carien L Creutzberg; Ignace Vergote; David Cibula; Mansoor Raza Mirza; Simone Marnitz; Jonathan A Ledermann; Tjalling Bosse; Cyrus Chargari; Anna Fagotti; Christina Fotopoulou; Antonio González-Martín; Sigurd F Lax; Domenica Lorusso; Christian Marth; Philippe Morice; Remi A Nout; Dearbhaile E O'Donnell; Denis Querleu; Maria Rosaria Raspollini; Jalid Sehouli; Alina E Sturdza; Alexandra Taylor; Anneke M Westermann; Pauline Wimberger; Nicoletta Colombo; François Planchamp; Xavier Matias-Guiu
Journal:  Virchows Arch       Date:  2021-02       Impact factor: 4.064

Review 7.  Progestins in the fertility-sparing treatment and retreatment of patients with primary and recurrent endometrial cancer.

Authors:  Jeong-Yeol Park; Joo-Hyun Nam
Journal:  Oncologist       Date:  2015-02-11

8.  Identification of a gene expression signature for survival prediction in type I endometrial carcinoma.

Authors:  Kristina Levan; Karolina Partheen; Lovisa Osterberg; Björn Olsson; Ulla Delle; Saskia Eklind; György Horvath
Journal:  Gene Expr       Date:  2010

9.  Response-specific progestin resistance in a newly characterized Ishikawa human endometrial cancer subcell line resulting from long-term exposure to medroxyprogesterone acetate.

Authors:  Shunjun Zhao; Genxia Li; Li Yang; Lei Li; Hongyu Li
Journal:  Oncol Lett       Date:  2012-10-17       Impact factor: 2.967

10.  Endometrial adenocarcinoma in a 27-year-old woman.

Authors:  Anis Fadhlaoui; Jamel Ben Hassouna; Mohamed Khrouf; Fethi Zhioua; Anis Chaker
Journal:  Clin Med Insights Case Rep       Date:  2010-08-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.